HEADER TRANSFERASE 04-DEC-08 3FFR TITLE CRYSTAL STRUCTURE OF A PHOSPHOSERINE AMINOTRANSFERASE SERC (CHU_0995) TITLE 2 FROM CYTOPHAGA HUTCHINSONII ATCC 33406 AT 1.75 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOSERINE AMINOTRANSFERASE SERC; COMPND 3 CHAIN: A; COMPND 4 EC: 2.6.1.52; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CYTOPHAGA HUTCHINSONII ATCC 33406; SOURCE 3 ORGANISM_TAXID: 269798; SOURCE 4 ATCC: 33406; SOURCE 5 GENE: CHU_0995, SERC, YP_677612.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PHOSPHOSERINE AMINOTRANSFERASE SERC, STRUCTURAL GENOMICS, JOINT KEYWDS 2 CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, KEYWDS 3 PSI-2, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3FFR 1 REMARK SEQADV HETSYN REVDAT 5 24-JUL-19 3FFR 1 REMARK LINK REVDAT 4 01-NOV-17 3FFR 1 REMARK REVDAT 3 13-JUL-11 3FFR 1 VERSN REVDAT 2 28-JUL-10 3FFR 1 TITLE KEYWDS REVDAT 1 23-DEC-08 3FFR 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PHOSPHOSERINE AMINOTRANSFERASE SERC (EC JRNL TITL 2 2.6.1.52) (YP_677612.1) FROM CYTOPHAGA HUTCHINSONII ATCC JRNL TITL 3 33406 AT 1.75 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 53552 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.144 REMARK 3 R VALUE (WORKING SET) : 0.143 REMARK 3 FREE R VALUE : 0.162 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2716 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3639 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.1840 REMARK 3 BIN FREE R VALUE SET COUNT : 206 REMARK 3 BIN FREE R VALUE : 0.2260 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2843 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 123 REMARK 3 SOLVENT ATOMS : 390 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 24.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.93000 REMARK 3 B22 (A**2) : -0.93000 REMARK 3 B33 (A**2) : 1.39000 REMARK 3 B12 (A**2) : -0.46000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.078 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.076 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.052 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.104 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.974 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.969 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3142 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2230 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4217 ; 1.675 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5502 ; 1.431 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 392 ; 4.206 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 130 ;32.470 ;24.769 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 556 ;10.424 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;20.981 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 463 ; 0.102 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3340 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 588 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1855 ; 1.445 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 744 ; 0.477 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3025 ; 2.227 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1287 ; 4.233 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1176 ; 6.539 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 361 REMARK 3 ORIGIN FOR THE GROUP (A): 38.2600 46.6750 59.6210 REMARK 3 T TENSOR REMARK 3 T11: -0.0702 T22: -0.0025 REMARK 3 T33: -0.0357 T12: 0.0106 REMARK 3 T13: 0.0088 T23: -0.0353 REMARK 3 L TENSOR REMARK 3 L11: 0.8332 L22: 0.4459 REMARK 3 L33: 0.6832 L12: -0.2301 REMARK 3 L13: -0.5332 L23: 0.3274 REMARK 3 S TENSOR REMARK 3 S11: 0.0884 S12: 0.1109 S13: 0.0023 REMARK 3 S21: -0.0544 S22: 0.0536 S23: -0.0424 REMARK 3 S31: -0.0822 S32: 0.0112 S33: -0.1420 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS REMARK 3 ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE REMARK 3 ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED REMARK 3 SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4. PEG-300 REMARK 3 (P33) MOLECULES FROM THE CRYSTALLIZATION SOLUTION ARE MODELED. REMARK 3 5. AN AMINO ACID SERINE HAS BEEN TENTATIVELY MODELED INTO REMARK 3 ELECTRON DENSITY IN THE PUTATIVE ACTIVE SITE. THIS ASSIGNMENT IS REMARK 3 BASED ON THE DENSITY FIT AND FUNCTIONAL ANNOTATION. A SERINE REMARK 3 COULD BE A PRECURSOR TO PHOSPHOSERINE WHICH IS A SUBSTRATE/ REMARK 3 PRODUCT OF THIS ENZYME. THIS LIGAND IS ADJACENT TO RESIDUE LYS REMARK 3 190, WHICH IS COVALENTLY LINKED TO A PYRIDOXAL-5'-PHOSPHATE (PLP) REMARK 3 MOLECULE WITH A SCHIFF BASE LINKAGE AND HAS BEEN MODELED AS LLP. REMARK 4 REMARK 4 3FFR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-08. REMARK 100 THE DEPOSITION ID IS D_1000050535. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97870,0.97821 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53599 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 26.698 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.3200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.57800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5.0000% PEG-1000, 40.0000% PEG-300, REMARK 280 0.1M TRIS PH 7.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.19667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 96.39333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 96.39333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 48.19667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT CRYSTAL PACKING ANALYSIS SUGGESTS THE REMARK 300 ASSIGNMENT OF A DIMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 144.59000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 38 CD CE NZ REMARK 470 ARG A 218 NE CZ NH1 NH2 REMARK 470 LYS A 268 CE NZ REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 315 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 155 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 155 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ASP A 205 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 47.05 -97.08 REMARK 500 PRO A 9 33.09 -86.06 REMARK 500 LYS A 83 -51.01 -128.94 REMARK 500 LYS A 83 -46.15 -131.84 REMARK 500 ASN A 90 12.17 -144.80 REMARK 500 SER A 170 -40.53 -138.02 REMARK 500 LLP A 190 -112.59 -107.21 REMARK 500 THR A 223 -101.60 -130.91 REMARK 500 SER A 262 150.51 91.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 P33 A 363 REMARK 610 P33 A 364 REMARK 610 P33 A 365 REMARK 610 P33 A 366 REMARK 610 P33 A 367 REMARK 610 P33 A 368 REMARK 610 P33 A 369 REMARK 610 P33 A 370 REMARK 610 P33 A 371 REMARK 610 P33 A 372 REMARK 610 P33 A 373 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SER A 362 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 363 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 364 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 365 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 366 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 367 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 368 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 369 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 370 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 371 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 372 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P33 A 373 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390729 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3FFR A 1 361 UNP Q11WE4 Q11WE4_CYTH3 1 361 SEQADV 3FFR GLY A 0 UNP Q11WE4 EXPRESSION TAG SEQRES 1 A 362 GLY MSE ASN ASN LYS ILE TYR PHE THR PRO GLY PRO SER SEQRES 2 A 362 GLU LEU TYR PRO THR VAL ARG GLN HIS MSE ILE THR ALA SEQRES 3 A 362 LEU ASP GLU LYS ILE GLY VAL ILE SER HIS ARG SER LYS SEQRES 4 A 362 LYS PHE GLU GLU VAL TYR LYS THR ALA SER ASP ASN LEU SEQRES 5 A 362 LYS THR LEU LEU GLU LEU PRO SER ASN TYR GLU VAL LEU SEQRES 6 A 362 PHE LEU ALA SER ALA THR GLU ILE TRP GLU ARG ILE ILE SEQRES 7 A 362 GLN ASN CYS VAL GLU LYS LYS SER PHE HIS CYS VAL ASN SEQRES 8 A 362 GLY SER PHE SER LYS ARG PHE TYR GLU PHE ALA GLY GLU SEQRES 9 A 362 LEU GLY ARG GLU ALA TYR LYS GLU GLU ALA ALA PHE GLY SEQRES 10 A 362 LYS GLY PHE TYR PRO ALA ASP ILE THR VAL PRO ALA ASP SEQRES 11 A 362 ALA GLU ILE ILE CYS LEU THR HIS ASN GLU THR SER SER SEQRES 12 A 362 GLY VAL SER MSE PRO VAL GLU ASP ILE ASN THR PHE ARG SEQRES 13 A 362 ASP LYS ASN LYS ASP ALA LEU ILE PHE VAL ASP ALA VAL SEQRES 14 A 362 SER SER LEU PRO TYR PRO LYS PHE ASP TRP THR LYS ILE SEQRES 15 A 362 ASP SER VAL PHE PHE SER VAL GLN LLP CYS PHE GLY LEU SEQRES 16 A 362 PRO ALA GLY LEU GLY VAL TRP ILE LEU ASN ASP ARG VAL SEQRES 17 A 362 ILE GLU LYS SER LYS ALA LEU LEU ALA LYS ARG LYS SER SEQRES 18 A 362 ILE GLY THR TYR HIS THR ILE PRO SER MSE LEU GLU LYS SEQRES 19 A 362 ALA ARG VAL ASN GLN THR PRO GLU THR PRO ASN ALA MSE SEQRES 20 A 362 ASN ILE PHE LEU LEU GLY LYS VAL THR GLY ASP MSE LEU SEQRES 21 A 362 GLN ILE SER ALA ASP GLY ILE ARG LYS GLN THR GLU GLU SEQRES 22 A 362 LYS ALA ALA LEU ILE ASN THR TYR ILE GLU SER SER LYS SEQRES 23 A 362 VAL PHE SER PHE GLY VAL GLU ASP ALA LYS LEU ARG SER SEQRES 24 A 362 MSE THR THR ILE VAL ALA ASN THR THR MSE LEU PRO GLY SEQRES 25 A 362 GLU ILE ASN LYS ILE LEU GLU PRO PHE ASP MSE ALA VAL SEQRES 26 A 362 GLY ALA GLY TYR GLY SER LYS LYS GLU THR GLN ILE ARG SEQRES 27 A 362 ILE ALA ASN PHE PRO ALA HIS SER LEU GLU GLN VAL HIS SEQRES 28 A 362 LYS LEU VAL GLN THR LEU LYS GLU LYS ILE GLY MODRES 3FFR MSE A 1 MET SELENOMETHIONINE MODRES 3FFR MSE A 22 MET SELENOMETHIONINE MODRES 3FFR MSE A 146 MET SELENOMETHIONINE MODRES 3FFR LLP A 190 LYS MODRES 3FFR MSE A 230 MET SELENOMETHIONINE MODRES 3FFR MSE A 246 MET SELENOMETHIONINE MODRES 3FFR MSE A 258 MET SELENOMETHIONINE MODRES 3FFR MSE A 299 MET SELENOMETHIONINE MODRES 3FFR MSE A 308 MET SELENOMETHIONINE MODRES 3FFR MSE A 322 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 22 8 HET MSE A 146 8 HET LLP A 190 24 HET MSE A 230 8 HET MSE A 246 8 HET MSE A 258 8 HET MSE A 299 8 HET MSE A 308 13 HET MSE A 322 8 HET SER A 362 7 HET P33 A 363 34 HET P33 A 364 16 HET P33 A 365 10 HET P33 A 366 10 HET P33 A 367 10 HET P33 A 368 12 HET P33 A 369 10 HET P33 A 370 10 HET P33 A 371 4 HET P33 A 372 7 HET P33 A 373 10 HETNAM MSE SELENOMETHIONINE HETNAM LLP (2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5- HETNAM 2 LLP (PHOSPHONOOXYMETHYL)PYRIDIN-4- HETNAM 3 LLP YL]METHYLIDENEAMINO]HEXANOIC ACID HETNAM SER SERINE HETNAM P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE HETSYN P33 HEPTAETHYLENE GLYCOL; PEG330 FORMUL 1 MSE 9(C5 H11 N O2 SE) FORMUL 1 LLP C14 H22 N3 O7 P FORMUL 2 SER C3 H7 N O3 FORMUL 3 P33 11(C14 H30 O8) FORMUL 14 HOH *390(H2 O) HELIX 1 1 THR A 17 GLU A 28 1 12 HELIX 2 2 SER A 37 LEU A 55 1 19 HELIX 3 3 SER A 68 VAL A 81 1 14 HELIX 4 4 GLY A 91 LEU A 104 1 14 HELIX 5 5 TYR A 120 ILE A 124 5 5 HELIX 6 6 PRO A 147 ASN A 152 1 6 HELIX 7 7 THR A 153 ASN A 158 5 6 HELIX 8 8 ASP A 205 LYS A 217 1 13 HELIX 9 9 THR A 226 ARG A 235 1 10 HELIX 10 10 ASN A 244 SER A 262 1 19 HELIX 11 11 SER A 262 SER A 284 1 23 HELIX 12 12 ASP A 293 ARG A 297 5 5 HELIX 13 13 LEU A 309 GLU A 318 1 10 HELIX 14 14 TYR A 328 LYS A 332 5 5 HELIX 15 15 SER A 345 ILE A 360 1 16 SHEET 1 A 5 ILE A 5 PHE A 7 0 SHEET 2 A 5 MSE A 322 ALA A 326 1 O ALA A 323 N PHE A 7 SHEET 3 A 5 GLN A 335 ALA A 339 -1 O ARG A 337 N GLY A 325 SHEET 4 A 5 THR A 301 THR A 306 -1 N ILE A 302 O ILE A 338 SHEET 5 A 5 PHE A 287 PHE A 289 -1 N SER A 288 O ASN A 305 SHEET 1 B 7 TYR A 61 LEU A 66 0 SHEET 2 B 7 GLY A 199 ASN A 204 -1 O TRP A 201 N LEU A 64 SHEET 3 B 7 SER A 183 SER A 187 -1 N PHE A 186 O VAL A 200 SHEET 4 B 7 LEU A 162 ASP A 166 1 N VAL A 165 O SER A 183 SHEET 5 B 7 ILE A 132 THR A 136 1 N LEU A 135 O PHE A 164 SHEET 6 B 7 LYS A 84 VAL A 89 1 N PHE A 86 O CYS A 134 SHEET 7 B 7 GLU A 107 GLU A 112 1 O TYR A 109 N SER A 85 LINK C GLY A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N ASN A 2 1555 1555 1.33 LINK C HIS A 21 N MSE A 22 1555 1555 1.34 LINK C MSE A 22 N ILE A 23 1555 1555 1.32 LINK C SER A 145 N MSE A 146 1555 1555 1.32 LINK C MSE A 146 N PRO A 147 1555 1555 1.34 LINK C GLN A 189 N LLP A 190 1555 1555 1.31 LINK C LLP A 190 N CYS A 191 1555 1555 1.32 LINK C SER A 229 N MSE A 230 1555 1555 1.33 LINK C MSE A 230 N LEU A 231 1555 1555 1.33 LINK C ALA A 245 N MSE A 246 1555 1555 1.33 LINK C MSE A 246 N ASN A 247 1555 1555 1.34 LINK C ASP A 257 N MSE A 258 1555 1555 1.33 LINK C MSE A 258 N LEU A 259 1555 1555 1.31 LINK C SER A 298 N MSE A 299 1555 1555 1.32 LINK C MSE A 299 N THR A 300 1555 1555 1.35 LINK C THR A 307 N MSE A 308 1555 1555 1.33 LINK C MSE A 308 N LEU A 309 1555 1555 1.32 LINK C ASP A 321 N MSE A 322 1555 1555 1.32 LINK C MSE A 322 N ALA A 323 1555 1555 1.33 CISPEP 1 GLY A 10 PRO A 11 0 -7.45 CISPEP 2 LEU A 171 PRO A 172 0 5.81 CISPEP 3 LEU A 171 PRO A 172 0 6.66 SITE 1 AC1 10 HIS A 35 ARG A 36 PHE A 93 ARG A 96 SITE 2 AC1 10 LLP A 190 TYR A 328 P33 A 364 P33 A 373 SITE 3 AC1 10 HOH A 397 HOH A 725 SITE 1 AC2 7 PHE A 115 ASN A 305 SER A 330 LYS A 331 SITE 2 AC2 7 THR A 334 GLN A 335 P33 A 366 SITE 1 AC3 9 ARG A 36 SER A 229 GLU A 232 LYS A 233 SITE 2 AC3 9 VAL A 236 GLN A 238 PRO A 240 SER A 362 SITE 3 AC3 9 HOH A 401 SITE 1 AC4 2 GLU A 103 GLU A 232 SITE 1 AC5 5 TYR A 328 SER A 330 P33 A 363 HOH A 395 SITE 2 AC5 5 HOH A 563 SITE 1 AC6 2 LYS A 357 GLU A 358 SITE 1 AC7 2 GLU A 358 LYS A 359 SITE 1 AC8 6 GLU A 82 GLU A 131 ASP A 160 LYS A 210 SITE 2 AC8 6 HOH A 665 HOH A 681 SITE 1 AC9 4 GLU A 149 ALA A 294 LYS A 295 HOH A 677 SITE 1 BC1 5 SER A 59 ASN A 60 GLU A 62 ARG A 235 SITE 2 BC1 5 HOH A 399 SITE 1 BC2 3 ASP A 49 THR A 53 HOH A 525 SITE 1 BC3 6 SER A 34 ARG A 36 TYR A 328 GLY A 329 SITE 2 BC3 6 SER A 362 HOH A 449 CRYST1 79.230 79.230 144.590 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012621 0.007287 0.000000 0.00000 SCALE2 0.000000 0.014574 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006916 0.00000